Navigation Links
DATATRAK Academy Expands to Include Durham Technical Community College
Date:5/10/2011

CLEVELAND, May 10, 2011 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announces the expansion of its DATATRAK Academy to include an agreement with Durham Technical Community College (DTCC) to license its DATATRAK eClinical® software suite. DTCC students and employees will use the eClinical software in its Clinical Trials Research program and courses. The software is used as part of the Clinical Trials Research Associate curriculum, which prepares individuals to assist investigators and clinical researchers in clinical research studies for the development of new drugs, clinical products, and treatment regimens.

"The DATATRAK Academy provides hands-on experience with the multitude of opportunities in the clinical research industry. It is a great method for recruiting the brightest, most innovative minds into our company, while at the same time, strengthening the bonds with our local communities and educating people on the importance of clinical trial research," stated Laurence P. Birch, DATATRAK's Chairman of the Board and CEO. "Expanding the Academy to include DTCC, allows its graduates to enter the field with prior electronic data capture experience. Not only are the program's graduates more marketable, but the industry benefits by having knowledgeable research associates to manage clinical trials."

DATATRAK Academy is an outreach program that furthers DATATRAK's vision of being the clinical enterprise solution to safely accelerate every drug, every biologic and every device from concept to cure. DATATRAK offers a unique program in conjunction with local academic institutions to provide hands-on experience in the clinical trials space; from software development to end-user training, the DATATRAK Academy advances the education of future healthcare industry participants.

About Durham Technical Community College

For nearly 50 years, Durham Technical Community College has provided high-quality, affordable, and convenient technical and career education; served as the springboard to a bachelor's degree; enabled tens of thousands of Triangle residents to enjoy continuing education offerings; and given many thousands more a second chance at success through adult literacy programs.  For more information on DTCC's Clinical Trials Research Associate degree, please see http://www.durhamtech.edu/programs/clintrials.htm.

About DATATRAK International, Inc.

DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK eClinical® unified software suite, deployed worldwide through an ASP or Enterprise Transfer offering, has successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 67 countries. DATATRAK has offices located in Cleveland, Ohio, and Bryan, Texas. For more information, visit http://www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 25, 2011 announcing its fourth quarter and full year results for 2010. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE DATATRAK International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. DATATRAK International, Inc. Announces Initial Equity Research Coverage by Zacks Investment Research
2. DAIICHI SANKYO EUROPE GmbH Selects DATATRAK eClinicalâ„¢ for Pan-European Systolic Hypertension Study
3. DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management
4. DATATRAK Exhibiting at the DIAs 46th Annual Meeting
5. DATATRAK Signs New Client for Rescue Study
6. DATATRAK International, Inc. to Release 2009 Second Quarter and First-Half Operating Results on August 17, 2009
7. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
8. At This Years American Academy of AntiAging (A4M) Conference, Glycation and AGEs (Advanced Glycation End Products) Were Named the Leading Factors in Premature Aging and Disease
9. VentiRx Pharmaceuticals Presents Positive Clinical and Pre-Clinical Data at American Academy of Allergy Asthma & Immunology Annual Meeting
10. MiMedx to Attend American Academy of Orthopedic Surgeons Annual Meeting
11. Renhuang Receives AAA(1) Rating from Chinese Academy of International Trade & Economic Cooperation of Ministry of Commerce
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... - New FDA action date of July 22, ... July 22, 2016   --> - ... 2016   - Lifitegrast has the potential to be ... of signs and symptoms of dry eye disease in adults ... only product approved in the U.S. in the past decade indicated for the treatment of ...
(Date:2/4/2016)... N.J. , Feb. 4, 2016  CytoSorbents ... immunotherapy leader commercializing its flagship CytoSorb® blood filter ... surgery patients around the world, announced that CEO ... present at the Source Capital Group,s 2016 Disruptive ... update on the company.  Conference ...
(Date:2/4/2016)... Feb. 4, 2016 Sinovac Biotech Ltd. ("Sinovac" ... provider of biopharmaceutical products in China ... board of directors received on February 4, 2016 a ... a consortium comprised of PKU V-Ming ( Shanghai ... Ltd., CICC Qianhai Development ( Shenzhen ) ...
(Date:2/3/2016)... , Feb. 3, 2016  Discovery Laboratories, ... focused on developing aerosolized KL4 surfactant therapies for ... Directors has approved an inducement award as a ... , its newly appointed President and Chief Executive ... Compensation Committee on February 1, 2016 and granted ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 This ... the bioinformatic market by reviewing the recent advances ... tools that drive the field forward. Includes forecast ... Identify the challenges and opportunities that exist ... and software solution developers, as well as IT ...
(Date:2/1/2016)... -- Rising sales of consumer electronics coupled ... gesture control market size through ... electronics coupled with new technological advancements to drive global ... through 2020   --> Rising ... to drive global touchfree intuitive gesture control market ...
(Date:1/25/2016)... 2016   Unisys Corporation (NYSE: UIS ) today ... (JFK) International Airport, New York City , to ... attempting to enter the United States using ... pilot testing of the system at Dulles last year. ... JFK during January 2016. --> pilot testing of ...
Breaking Biology News(10 mins):